Along with RUNX1, FLI1 is also a critical regulator of embryonic hematopoiesis24,39; thus, compensatory epigenetic downregulation of RUNX1 and FLI1 may be required for viable embryogenic development in DS, but potentially also results in increased risk of hematological malignancies. This evidence concerns the gene RUNX1 and Dravet syndrome.